bell
The current prices are delayed by 15 mins, login to check live prices.
ERIS Lifesciences Ltd share price logo

ERIS Lifesciences Ltd Share Price

(ERIS)

₹1290.150.78%

as on 04:01PM, 17 Jan 2025

Overview
News
Financials
Q3 2024 Results
Technicals

ERIS Lifesciences Ltd Analyst Rating

based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts offering long term price targets for ERIS Lifesciences Ltd. An average target of ₹1510.33

Source: S&P Global Market Intelligence

ERIS Lifesciences Ltd Share analysis

ERIS Lifesciences Ltd price forecast by 9 analysts

Upside of17.07%

High

₹1680

Target

₹1510.33

Low

₹1230

ERIS Lifesciences Ltd target price ₹1510.33, a slight upside of 17.07% compared to current price of ₹1290.15. According to 9 analysts rating.

Source: S&P Global Market Intelligence

ERIS Lifesciences Ltd Performance

  • Day's Low

    Day's High

    ₹1,280.45
    Day's Price Range
    ₹1,308.45
  • 52 Week's Low

    52 Week's High

    ₹809.15
    52-Week Price Range
    ₹1,593.9
1 Month Return-7.14 %
3 Month Return-4.1 %
1 Year Return+ 44.41 %
Previous Close₹1,300.25
Open₹1,300.50
Volume43.09K
Upper Circuit-
Lower Circuit-
Market Cap₹17,700.21Cr

ERIS Lifesciences Ltd Key Statistics

P/E Ratio50.38
PEG Ratio-18.39
Market Cap₹17,700.21 Cr
P/B Ratio4.53
EPS29.19
Dividend Yield0
SectorPharmaceuticals
ROE12.63

ERIS Lifesciences Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹17,700.21 Cr31.01%0.75₹397 Cr₹2,056 Cr
NA₹10.17 Cr94.34%0.88NANA
NA₹261.26 Cr97.58%0.52₹16 Cr₹108 Cr
NA₹122.53 Cr40.58%0.51NANA
NA₹14,909.73 Cr-1.26%0.73₹82 Cr₹1,465 Cr

About ERIS Lifesciences Ltd

Eris Lifesciences Limited was incorporated in 2007 and is engaged in manufacturing, distributing and marketing of branded pharmaceutical products, having presence in high growth chronic, sub-chronic and acute therapeutic areas. It has a portfolio of 112 Mother Brands across therapy areas and 5 subsidiaries, 4 of which are wholly owned subsidiaries. The company has made two acquisitions - UTH Healthcare Ltd for Rs 129 million for its product portfolio in 2017 and Indian branded formulations business Strides for Rs 5000 crore in 2017. It made its debut in secondary equity market in 2017 and in FY 2018 capital expenditure amounted to Rs 242.69 million and Rs 5061.52 million was paid towards business acquisition. In FY 2019 the company expanded its operations by constructing new softgel facility, extended facility for supplements and nutraceuticals, and added Zomelis products in its portfolio. In 2020, Kinedex became wholly owned subsidiary and the company launched new business divisions. In FY21 it launched Gluxit in SGLT2 segment, Eritel and LNBloc maintained ranks in their respective segments, developed Bricet and fortified portfolio with the launch of ZACD. In FY22 it acquired 100 stake in Oaknet Healthcare Ltd worth Rs 6500 million and launched human insulin through its subsidiary Eris M.J. Biopharm Ltd and Xsulin in vials and cartridges.

Share Price: ₹1290.15 per share as on 17 Jan, 2025 04:01 PM
Market Capitalisation: ₹17,700.21Cr as of today
Revenue: ₹738.95Cr as on September 2024 (Q3 24)
Net Profit: ₹96.35Cr as on September 2024 (Q3 24)
Listing date: 29 Jun, 2017
Chairperson Name: Amit Indubhushan Bakshi
OrganisationERIS Lifesciences Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for ERIS Lifesciences Ltd

  • Eris Lifesciences Added to Smallcap and Midcap Portfolios - 15 Jan, 2025

    Eris Lifesciences has been included in smallcap and midcap portfolios due to its focus on chronic therapies, which yield higher profit margins. Despite a 5% decline over the last three months, the stock has more than doubled in the past two years.
  • Eris Lifesciences Shows Potential for Bullish Revival - 14 Jan, 2025

    Eris Lifesciences is trading near a key support level, indicating strong demand. Technical indicators suggest a potential bullish reversal, with a target price of ₹1,400.

Insights on ERIS Lifesciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, ERIS stock has moved up by 23.0%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 14.52% to 17.03% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 490.49 Cr → 745.72 Cr (in ₹), with an average increase of 12.7% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 14.30% to 18.47% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 70.96 Cr → 91.59 Cr (in ₹), with an average increase of 11.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 35.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 10.9%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 54.88% to 54.87% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 14.59% to 8.01% in Sep 2024 quarter

ERIS Lifesciences Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹500.52Cr (-)₹483.48Cr (↓3.40%)₹547.27Cr (↑13.19%)₹715.59Cr (↑30.76%)₹738.95Cr (↑3.26%)
Net Income₹122.31Cr (-)₹101.46Cr (↓17.05%)₹79.63Cr (↓21.52%)₹89.42Cr (↑12.29%)₹96.35Cr (↑7.75%)
Net Profit Margin24.44% (-)20.99% (↓14.12%)14.55% (↓30.68%)12.50% (↓14.09%)13.04% (↑4.32%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,855.34Cr (-)₹2,265.02Cr (↑22.08%)₹2,909.02Cr (↑28.43%)₹5,530.88Cr (↑90.13%)
Total Liabilities₹279.87Cr (-)₹346.47Cr (↑23.80%)₹687.13Cr (↑98.32%)₹3,006.86Cr (↑337.60%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹265.25Cr (-)₹395.41Cr (↑49.07%)₹369.41Cr (↓6.58%)₹322.33Cr (↓12.74%)₹336.29Cr (↑4.33%)

Index Inclusions

BSE Healthcare

₹42,660.26

0.22 (95.19%)

Nifty Smallcap 250

₹16,700.50

-0.04 (-7.4%)

Nifty 500

₹21,680.25

-0.16 (-34.3%)

BSE 500

₹34,083.34

-0.16 (-53.44%)

S&P BSE 400 MidSmallCap

₹11,515.38

0.04 (4.9%)

S&P BSE 250 SmallCap

₹6,677.71

-0.04 (-2.74%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Nifty MidSmallcap 400

₹18,978.85

0.06 (10.9%)

BSE Small-Cap

₹52,311.31

0.01 (2.64%)

ERIS Lifesciences Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
54.87%
-0.02
Foreign Institutions
8.01%
-45.07
Mutual Funds
17.03%
17.28
Retail Investors
18.47%
29.19
Others
1.61%
-5.57

ERIS Lifesciences Ltd Key Indicators

Details20202021202220232024
Return On Equity %23.7224.3923.8819.2312.63
Details20202021202220232024
Return On Assets %19.0119.1417.9313.147.09
Details20202021202220232024
Book Value Per Share (₹)95.47116.1140.36161.48190.11
Details20202021202220232024
Earning Per Share (₹)21.8426.1629.8527.5129.19

ERIS Lifesciences Ltd Valuation

ERIS Lifesciences Ltd in the last 5 years

  • Overview

  • Trends

Lowest (16.77x)

September 9, 2019

Today (50.38x)

January 17, 2025

Industry (54.95x)

January 17, 2025

Highest (59.46x)

December 11, 2024

LowHigh

ERIS Lifesciences Ltd Earnings and Dividends

  • ERIS Lifesciences Ltd Earnings Results

    ERIS Lifesciences Ltd’s net profit fell -25.8% since last year same period to ₹91.59Cr in the Q2 2024-2025. On a quarterly growth basis, ERIS Lifesciences Ltd has generated 10.11% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • ERIS Lifesciences Ltd Dividends August,2022

    In the quarter ending June 2022, ERIS Lifesciences Ltd has declared dividend of ₹7.35 - translating a dividend yield of 0.57%.

    Read More about Dividends

ERIS Lifesciences Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

ERIS Lifesciences Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on ERIS Lifesciences Ltd

ERIS Lifesciences Ltd share price today stands at ₹1290.15, Open. ₹1300.5 ; Previous Close. ₹1300.25 ; High. ₹1308.45 ; Low. ₹1280.45 ; 52 Week High. ₹1593.9 ; 52 Week Low: ₹809.15.

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy ERIS Lifesciences Ltd shares.

ERIS Lifesciences Ltd is listed on NSE

ERIS Lifesciences Ltd is listed on BSE

  • Today’s highest price of ERIS Lifesciences Ltd is ₹1308.45.
  • Today’s lowest price of ERIS Lifesciences Ltd is ₹1280.45.

PE Ratio of ERIS Lifesciences Ltd is 50.38

PE ratio = ERIS Lifesciences Ltd Market price per share / ERIS Lifesciences Ltd Earnings per share

Today’s traded volume of ERIS Lifesciences Ltd(ERIS) is 43.09K.

Today’s market capitalisation of ERIS Lifesciences Ltd(ERIS) is ₹17700.21Cr.

ERIS Lifesciences Ltd(ERISPrice
52 Week High
₹1593.9
52 Week Low
₹809.15

ERIS Lifesciences Ltd(ERIS) share price is ₹1290.15. It is down -19.06% from its 52 Week High price of ₹1593.9

ERIS Lifesciences Ltd(ERIS) share price is ₹1290.15. It is up 59.45% from its 52 Week Low price of ₹809.15

ERIS Lifesciences Ltd(ERISReturns
1 Day Returns
-10.1%
1 Month Returns
-7.14%
3 Month Returns
-4.1%
1 Year Returns
44.41%